GTJA Investment Group is a Shenzhen based venture capital firm investing in healthcare companies in China and Asia. The company offers venture capital, private equity, direct investment, and asset management business services for healthcare startups. Founded in 2001, as of 2019, it claims to have ￥20 billion AUM (Assets Under Management) and has raised 24 funds dedicating to the healthcare industry. It has invested in companies involved in medical device manufacturing, medical diagnosis and treatment, chronic disease management, plastic surgery, and pharmaceuticals.
Akeso Biopharma is a biotechnology and biopharmaceutical company focused on the research and development of new pharmaceutical products and founded in 2012.